nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR1D—meninx—sarcoma	0.0475	0.212	CbGeAlD
Pramipexole—HTR1B—dura mater—sarcoma	0.0452	0.201	CbGeAlD
Pramipexole—HTR1D—dura mater—sarcoma	0.0437	0.195	CbGeAlD
Pramipexole—HTR2A—pulmonary artery—sarcoma	0.00927	0.0413	CbGeAlD
Pramipexole—HTR2A—hindlimb—sarcoma	0.00561	0.025	CbGeAlD
Pramipexole—HTR2A—appendage—sarcoma	0.00481	0.0214	CbGeAlD
Pramipexole—DRD5—hematopoietic system—sarcoma	0.00479	0.0214	CbGeAlD
Pramipexole—DRD4—testis—sarcoma	0.00398	0.0178	CbGeAlD
Pramipexole—DRD5—lymphoid tissue—sarcoma	0.00337	0.015	CbGeAlD
Pramipexole—HTR2B—myometrium—sarcoma	0.00311	0.0139	CbGeAlD
Pramipexole—HTR2A—endothelium—sarcoma	0.0029	0.0129	CbGeAlD
Pramipexole—HTR1D—connective tissue—sarcoma	0.00276	0.0123	CbGeAlD
Pramipexole—ADRA2C—myometrium—sarcoma	0.00245	0.0109	CbGeAlD
Pramipexole—HTR1A—hematopoietic system—sarcoma	0.00239	0.0107	CbGeAlD
Pramipexole—HTR2B—smooth muscle tissue—sarcoma	0.00235	0.0105	CbGeAlD
Pramipexole—HTR2B—skin of body—sarcoma	0.00232	0.0104	CbGeAlD
Pramipexole—ADRA2C—seminal vesicle—sarcoma	0.00221	0.00986	CbGeAlD
Pramipexole—HTR2B—uterus—sarcoma	0.00202	0.00899	CbGeAlD
Pramipexole—ADRA2A—myometrium—sarcoma	0.00195	0.00871	CbGeAlD
Pramipexole—HTR2B—tendon—sarcoma	0.00177	0.00788	CbGeAlD
Pramipexole—ADRA2A—seminal vesicle—sarcoma	0.00176	0.00787	CbGeAlD
Pramipexole—ADRA2A—hematopoietic system—sarcoma	0.00168	0.00748	CbGeAlD
Pramipexole—ADRA2A—connective tissue—sarcoma	0.00161	0.0072	CbGeAlD
Pramipexole—HTR2A—embryo—sarcoma	0.0016	0.00712	CbGeAlD
Pramipexole—ADRA2C—cardiac atrium—sarcoma	0.0016	0.00712	CbGeAlD
Pramipexole—ADRA2C—uterus—sarcoma	0.00159	0.00708	CbGeAlD
Pramipexole—SLC22A1—liver—sarcoma	0.0015	0.00669	CbGeAlD
Pramipexole—HTR2A—hematopoietic system—sarcoma	0.00143	0.00636	CbGeAlD
Pramipexole—ADRA2C—tendon—sarcoma	0.00139	0.0062	CbGeAlD
Pramipexole—HTR2A—connective tissue—sarcoma	0.00137	0.00612	CbGeAlD
Pramipexole—ADRA2A—cardiac atrium—sarcoma	0.00127	0.00568	CbGeAlD
Pramipexole—ADRA2A—uterus—sarcoma	0.00127	0.00565	CbGeAlD
Pramipexole—HTR2A—smooth muscle tissue—sarcoma	0.00126	0.0056	CbGeAlD
Pramipexole—DRD2—testis—sarcoma	0.00118	0.00528	CbGeAlD
Pramipexole—ADRA2C—testis—sarcoma	0.00115	0.00514	CbGeAlD
Pramipexole—ADRA2A—tendon—sarcoma	0.00111	0.00495	CbGeAlD
Pramipexole—ADRA2C—liver—sarcoma	0.00109	0.00486	CbGeAlD
Pramipexole—HTR2B—lymph node—sarcoma	0.00106	0.00473	CbGeAlD
Pramipexole—HTR2A—tendon—sarcoma	0.000944	0.00421	CbGeAlD
Pramipexole—ADRA2A—testis—sarcoma	0.000919	0.0041	CbGeAlD
Pramipexole—ADRA2C—lymph node—sarcoma	0.000835	0.00372	CbGeAlD
Pramipexole—HTR2A—testis—sarcoma	0.000781	0.00348	CbGeAlD
Pramipexole—HTR2A—liver—sarcoma	0.000739	0.00329	CbGeAlD
Pramipexole—ADRA2A—lymph node—sarcoma	0.000666	0.00297	CbGeAlD
Pramipexole—Dyspnoea—Etoposide—sarcoma	0.000393	0.000507	CcSEcCtD
Pramipexole—Hyperglycaemia—Epirubicin—sarcoma	0.000392	0.000506	CcSEcCtD
Pramipexole—Somnolence—Etoposide—sarcoma	0.000392	0.000506	CcSEcCtD
Pramipexole—Angina pectoris—Doxorubicin—sarcoma	0.000392	0.000505	CcSEcCtD
Pramipexole—Hypersensitivity—Mitoxantrone—sarcoma	0.000391	0.000504	CcSEcCtD
Pramipexole—Asthenia—Vincristine—sarcoma	0.000391	0.000504	CcSEcCtD
Pramipexole—Vomiting—Thiotepa—sarcoma	0.00039	0.000503	CcSEcCtD
Pramipexole—Pneumonia—Epirubicin—sarcoma	0.00039	0.000503	CcSEcCtD
Pramipexole—Infestation NOS—Epirubicin—sarcoma	0.000388	0.0005	CcSEcCtD
Pramipexole—Drowsiness—Epirubicin—sarcoma	0.000388	0.0005	CcSEcCtD
Pramipexole—Infestation—Epirubicin—sarcoma	0.000388	0.0005	CcSEcCtD
Pramipexole—Vomiting—Dactinomycin—sarcoma	0.000388	0.0005	CcSEcCtD
Pramipexole—Rash—Thiotepa—sarcoma	0.000387	0.000499	CcSEcCtD
Pramipexole—Bronchitis—Doxorubicin—sarcoma	0.000387	0.000499	CcSEcCtD
Pramipexole—Dermatitis—Thiotepa—sarcoma	0.000387	0.000499	CcSEcCtD
Pramipexole—Headache—Thiotepa—sarcoma	0.000385	0.000496	CcSEcCtD
Pramipexole—Rash—Dactinomycin—sarcoma	0.000384	0.000495	CcSEcCtD
Pramipexole—Decreased appetite—Etoposide—sarcoma	0.000383	0.000494	CcSEcCtD
Pramipexole—Renal failure—Epirubicin—sarcoma	0.000381	0.000491	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Etoposide—sarcoma	0.000381	0.000491	CcSEcCtD
Pramipexole—Asthenia—Mitoxantrone—sarcoma	0.000381	0.000491	CcSEcCtD
Pramipexole—Fatigue—Etoposide—sarcoma	0.00038	0.00049	CcSEcCtD
Pramipexole—Neuropathy peripheral—Epirubicin—sarcoma	0.00038	0.00049	CcSEcCtD
Pramipexole—Constipation—Etoposide—sarcoma	0.000377	0.000486	CcSEcCtD
Pramipexole—Pain—Etoposide—sarcoma	0.000377	0.000486	CcSEcCtD
Pramipexole—Conjunctivitis—Epirubicin—sarcoma	0.000377	0.000486	CcSEcCtD
Pramipexole—Urinary tract infection—Epirubicin—sarcoma	0.000377	0.000486	CcSEcCtD
Pramipexole—Dysuria—Doxorubicin—sarcoma	0.000376	0.000485	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000374	0.000482	CcSEcCtD
Pramipexole—Diarrhoea—Vincristine—sarcoma	0.000373	0.00048	CcSEcCtD
Pramipexole—Sweating—Epirubicin—sarcoma	0.000372	0.000479	CcSEcCtD
Pramipexole—Pollakiuria—Doxorubicin—sarcoma	0.000372	0.000479	CcSEcCtD
Pramipexole—Haematuria—Epirubicin—sarcoma	0.00037	0.000477	CcSEcCtD
Pramipexole—Photosensitivity reaction—Doxorubicin—sarcoma	0.000367	0.000473	CcSEcCtD
Pramipexole—Hepatobiliary disease—Epirubicin—sarcoma	0.000367	0.000473	CcSEcCtD
Pramipexole—Weight increased—Doxorubicin—sarcoma	0.000366	0.000472	CcSEcCtD
Pramipexole—Epistaxis—Epirubicin—sarcoma	0.000366	0.000471	CcSEcCtD
Pramipexole—Nausea—Thiotepa—sarcoma	0.000365	0.00047	CcSEcCtD
Pramipexole—Weight decreased—Doxorubicin—sarcoma	0.000364	0.000469	CcSEcCtD
Pramipexole—Sinusitis—Epirubicin—sarcoma	0.000364	0.000469	CcSEcCtD
Pramipexole—Feeling abnormal—Etoposide—sarcoma	0.000364	0.000469	CcSEcCtD
Pramipexole—Hyperglycaemia—Doxorubicin—sarcoma	0.000363	0.000468	CcSEcCtD
Pramipexole—Diarrhoea—Mitoxantrone—sarcoma	0.000363	0.000468	CcSEcCtD
Pramipexole—Nausea—Dactinomycin—sarcoma	0.000362	0.000467	CcSEcCtD
Pramipexole—Pneumonia—Doxorubicin—sarcoma	0.000361	0.000465	CcSEcCtD
Pramipexole—Gastrointestinal pain—Etoposide—sarcoma	0.000361	0.000465	CcSEcCtD
Pramipexole—Dizziness—Vincristine—sarcoma	0.00036	0.000464	CcSEcCtD
Pramipexole—Drowsiness—Doxorubicin—sarcoma	0.000359	0.000462	CcSEcCtD
Pramipexole—Infestation NOS—Doxorubicin—sarcoma	0.000359	0.000462	CcSEcCtD
Pramipexole—Infestation—Doxorubicin—sarcoma	0.000359	0.000462	CcSEcCtD
Pramipexole—Bradycardia—Epirubicin—sarcoma	0.000354	0.000457	CcSEcCtD
Pramipexole—Renal failure—Doxorubicin—sarcoma	0.000353	0.000455	CcSEcCtD
Pramipexole—Neuropathy peripheral—Doxorubicin—sarcoma	0.000352	0.000453	CcSEcCtD
Pramipexole—Urticaria—Etoposide—sarcoma	0.00035	0.000452	CcSEcCtD
Pramipexole—Rhinitis—Epirubicin—sarcoma	0.000349	0.00045	CcSEcCtD
Pramipexole—Abdominal pain—Etoposide—sarcoma	0.000349	0.00045	CcSEcCtD
Pramipexole—Body temperature increased—Etoposide—sarcoma	0.000349	0.00045	CcSEcCtD
Pramipexole—Urinary tract infection—Doxorubicin—sarcoma	0.000349	0.00045	CcSEcCtD
Pramipexole—Conjunctivitis—Doxorubicin—sarcoma	0.000349	0.00045	CcSEcCtD
Pramipexole—Hypoaesthesia—Epirubicin—sarcoma	0.000346	0.000446	CcSEcCtD
Pramipexole—Vomiting—Vincristine—sarcoma	0.000346	0.000446	CcSEcCtD
Pramipexole—Pharyngitis—Epirubicin—sarcoma	0.000345	0.000445	CcSEcCtD
Pramipexole—Sweating—Doxorubicin—sarcoma	0.000344	0.000443	CcSEcCtD
Pramipexole—Urinary tract disorder—Epirubicin—sarcoma	0.000344	0.000443	CcSEcCtD
Pramipexole—Rash—Vincristine—sarcoma	0.000343	0.000443	CcSEcCtD
Pramipexole—Dermatitis—Vincristine—sarcoma	0.000343	0.000442	CcSEcCtD
Pramipexole—Oedema peripheral—Epirubicin—sarcoma	0.000343	0.000442	CcSEcCtD
Pramipexole—Haematuria—Doxorubicin—sarcoma	0.000342	0.000441	CcSEcCtD
Pramipexole—Connective tissue disorder—Epirubicin—sarcoma	0.000342	0.000441	CcSEcCtD
Pramipexole—Urethral disorder—Epirubicin—sarcoma	0.000341	0.00044	CcSEcCtD
Pramipexole—Headache—Vincristine—sarcoma	0.000341	0.00044	CcSEcCtD
Pramipexole—Hepatobiliary disease—Doxorubicin—sarcoma	0.000339	0.000437	CcSEcCtD
Pramipexole—Epistaxis—Doxorubicin—sarcoma	0.000338	0.000436	CcSEcCtD
Pramipexole—Vomiting—Mitoxantrone—sarcoma	0.000337	0.000435	CcSEcCtD
Pramipexole—Sinusitis—Doxorubicin—sarcoma	0.000337	0.000434	CcSEcCtD
Pramipexole—Visual impairment—Epirubicin—sarcoma	0.000335	0.000432	CcSEcCtD
Pramipexole—Rash—Mitoxantrone—sarcoma	0.000334	0.000431	CcSEcCtD
Pramipexole—Dermatitis—Mitoxantrone—sarcoma	0.000334	0.000431	CcSEcCtD
Pramipexole—Headache—Mitoxantrone—sarcoma	0.000332	0.000428	CcSEcCtD
Pramipexole—Bradycardia—Doxorubicin—sarcoma	0.000328	0.000423	CcSEcCtD
Pramipexole—Eye disorder—Epirubicin—sarcoma	0.000325	0.000419	CcSEcCtD
Pramipexole—Hypersensitivity—Etoposide—sarcoma	0.000325	0.000419	CcSEcCtD
Pramipexole—Tinnitus—Epirubicin—sarcoma	0.000325	0.000418	CcSEcCtD
Pramipexole—Nausea—Vincristine—sarcoma	0.000323	0.000417	CcSEcCtD
Pramipexole—Cardiac disorder—Epirubicin—sarcoma	0.000323	0.000416	CcSEcCtD
Pramipexole—Flushing—Epirubicin—sarcoma	0.000323	0.000416	CcSEcCtD
Pramipexole—Rhinitis—Doxorubicin—sarcoma	0.000323	0.000416	CcSEcCtD
Pramipexole—Hypoaesthesia—Doxorubicin—sarcoma	0.00032	0.000413	CcSEcCtD
Pramipexole—Pharyngitis—Doxorubicin—sarcoma	0.00032	0.000412	CcSEcCtD
Pramipexole—Urinary tract disorder—Doxorubicin—sarcoma	0.000318	0.00041	CcSEcCtD
Pramipexole—Oedema peripheral—Doxorubicin—sarcoma	0.000317	0.000409	CcSEcCtD
Pramipexole—Asthenia—Etoposide—sarcoma	0.000317	0.000408	CcSEcCtD
Pramipexole—Connective tissue disorder—Doxorubicin—sarcoma	0.000316	0.000408	CcSEcCtD
Pramipexole—Angiopathy—Epirubicin—sarcoma	0.000316	0.000407	CcSEcCtD
Pramipexole—Urethral disorder—Doxorubicin—sarcoma	0.000316	0.000407	CcSEcCtD
Pramipexole—Nausea—Mitoxantrone—sarcoma	0.000315	0.000406	CcSEcCtD
Pramipexole—Immune system disorder—Epirubicin—sarcoma	0.000314	0.000405	CcSEcCtD
Pramipexole—Mediastinal disorder—Epirubicin—sarcoma	0.000314	0.000404	CcSEcCtD
Pramipexole—Chills—Epirubicin—sarcoma	0.000312	0.000403	CcSEcCtD
Pramipexole—Pruritus—Etoposide—sarcoma	0.000312	0.000402	CcSEcCtD
Pramipexole—Visual impairment—Doxorubicin—sarcoma	0.00031	0.0004	CcSEcCtD
Pramipexole—Alopecia—Epirubicin—sarcoma	0.000308	0.000396	CcSEcCtD
Pramipexole—Mental disorder—Epirubicin—sarcoma	0.000305	0.000393	CcSEcCtD
Pramipexole—Malnutrition—Epirubicin—sarcoma	0.000303	0.000391	CcSEcCtD
Pramipexole—Erythema—Epirubicin—sarcoma	0.000303	0.000391	CcSEcCtD
Pramipexole—Diarrhoea—Etoposide—sarcoma	0.000302	0.000389	CcSEcCtD
Pramipexole—Eye disorder—Doxorubicin—sarcoma	0.000301	0.000388	CcSEcCtD
Pramipexole—Tinnitus—Doxorubicin—sarcoma	0.0003	0.000387	CcSEcCtD
Pramipexole—Flushing—Doxorubicin—sarcoma	0.000299	0.000385	CcSEcCtD
Pramipexole—Cardiac disorder—Doxorubicin—sarcoma	0.000299	0.000385	CcSEcCtD
Pramipexole—Flatulence—Epirubicin—sarcoma	0.000299	0.000385	CcSEcCtD
Pramipexole—Tension—Epirubicin—sarcoma	0.000297	0.000383	CcSEcCtD
Pramipexole—Dysgeusia—Epirubicin—sarcoma	0.000297	0.000382	CcSEcCtD
Pramipexole—Nervousness—Epirubicin—sarcoma	0.000294	0.000379	CcSEcCtD
Pramipexole—Back pain—Epirubicin—sarcoma	0.000293	0.000378	CcSEcCtD
Pramipexole—Angiopathy—Doxorubicin—sarcoma	0.000292	0.000377	CcSEcCtD
Pramipexole—Dizziness—Etoposide—sarcoma	0.000292	0.000376	CcSEcCtD
Pramipexole—Muscle spasms—Epirubicin—sarcoma	0.000291	0.000376	CcSEcCtD
Pramipexole—Immune system disorder—Doxorubicin—sarcoma	0.000291	0.000375	CcSEcCtD
Pramipexole—Mediastinal disorder—Doxorubicin—sarcoma	0.00029	0.000374	CcSEcCtD
Pramipexole—Chills—Doxorubicin—sarcoma	0.000289	0.000373	CcSEcCtD
Pramipexole—Vision blurred—Epirubicin—sarcoma	0.000286	0.000368	CcSEcCtD
Pramipexole—Alopecia—Doxorubicin—sarcoma	0.000285	0.000367	CcSEcCtD
Pramipexole—Mental disorder—Doxorubicin—sarcoma	0.000282	0.000364	CcSEcCtD
Pramipexole—Ill-defined disorder—Epirubicin—sarcoma	0.000281	0.000362	CcSEcCtD
Pramipexole—Vomiting—Etoposide—sarcoma	0.00028	0.000362	CcSEcCtD
Pramipexole—Malnutrition—Doxorubicin—sarcoma	0.00028	0.000361	CcSEcCtD
Pramipexole—Erythema—Doxorubicin—sarcoma	0.00028	0.000361	CcSEcCtD
Pramipexole—Anaemia—Epirubicin—sarcoma	0.00028	0.000361	CcSEcCtD
Pramipexole—Agitation—Epirubicin—sarcoma	0.000278	0.000359	CcSEcCtD
Pramipexole—Rash—Etoposide—sarcoma	0.000278	0.000359	CcSEcCtD
Pramipexole—Dermatitis—Etoposide—sarcoma	0.000278	0.000358	CcSEcCtD
Pramipexole—Headache—Etoposide—sarcoma	0.000276	0.000356	CcSEcCtD
Pramipexole—Flatulence—Doxorubicin—sarcoma	0.000276	0.000356	CcSEcCtD
Pramipexole—Tension—Doxorubicin—sarcoma	0.000275	0.000355	CcSEcCtD
Pramipexole—Dysgeusia—Doxorubicin—sarcoma	0.000275	0.000354	CcSEcCtD
Pramipexole—Malaise—Epirubicin—sarcoma	0.000273	0.000352	CcSEcCtD
Pramipexole—Nervousness—Doxorubicin—sarcoma	0.000272	0.000351	CcSEcCtD
Pramipexole—Vertigo—Epirubicin—sarcoma	0.000272	0.000351	CcSEcCtD
Pramipexole—Syncope—Epirubicin—sarcoma	0.000272	0.00035	CcSEcCtD
Pramipexole—Leukopenia—Epirubicin—sarcoma	0.000271	0.00035	CcSEcCtD
Pramipexole—Back pain—Doxorubicin—sarcoma	0.000271	0.00035	CcSEcCtD
Pramipexole—Muscle spasms—Doxorubicin—sarcoma	0.00027	0.000347	CcSEcCtD
Pramipexole—Palpitations—Epirubicin—sarcoma	0.000268	0.000345	CcSEcCtD
Pramipexole—Loss of consciousness—Epirubicin—sarcoma	0.000266	0.000343	CcSEcCtD
Pramipexole—Cough—Epirubicin—sarcoma	0.000264	0.000341	CcSEcCtD
Pramipexole—Vision blurred—Doxorubicin—sarcoma	0.000264	0.000341	CcSEcCtD
Pramipexole—Convulsion—Epirubicin—sarcoma	0.000263	0.000338	CcSEcCtD
Pramipexole—Nausea—Etoposide—sarcoma	0.000262	0.000338	CcSEcCtD
Pramipexole—Hypertension—Epirubicin—sarcoma	0.000262	0.000337	CcSEcCtD
Pramipexole—Ill-defined disorder—Doxorubicin—sarcoma	0.00026	0.000335	CcSEcCtD
Pramipexole—Anaemia—Doxorubicin—sarcoma	0.000259	0.000334	CcSEcCtD
Pramipexole—Chest pain—Epirubicin—sarcoma	0.000258	0.000333	CcSEcCtD
Pramipexole—Myalgia—Epirubicin—sarcoma	0.000258	0.000333	CcSEcCtD
Pramipexole—Arthralgia—Epirubicin—sarcoma	0.000258	0.000333	CcSEcCtD
Pramipexole—Agitation—Doxorubicin—sarcoma	0.000258	0.000332	CcSEcCtD
Pramipexole—Anxiety—Epirubicin—sarcoma	0.000257	0.000331	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000256	0.00033	CcSEcCtD
Pramipexole—Discomfort—Epirubicin—sarcoma	0.000255	0.000329	CcSEcCtD
Pramipexole—Malaise—Doxorubicin—sarcoma	0.000253	0.000326	CcSEcCtD
Pramipexole—Dry mouth—Epirubicin—sarcoma	0.000252	0.000325	CcSEcCtD
Pramipexole—Vertigo—Doxorubicin—sarcoma	0.000252	0.000325	CcSEcCtD
Pramipexole—Syncope—Doxorubicin—sarcoma	0.000251	0.000324	CcSEcCtD
Pramipexole—Leukopenia—Doxorubicin—sarcoma	0.000251	0.000323	CcSEcCtD
Pramipexole—Confusional state—Epirubicin—sarcoma	0.000249	0.000321	CcSEcCtD
Pramipexole—Palpitations—Doxorubicin—sarcoma	0.000248	0.000319	CcSEcCtD
Pramipexole—Oedema—Epirubicin—sarcoma	0.000247	0.000319	CcSEcCtD
Pramipexole—Loss of consciousness—Doxorubicin—sarcoma	0.000246	0.000318	CcSEcCtD
Pramipexole—Infection—Epirubicin—sarcoma	0.000246	0.000317	CcSEcCtD
Pramipexole—Cough—Doxorubicin—sarcoma	0.000245	0.000315	CcSEcCtD
Pramipexole—Shock—Epirubicin—sarcoma	0.000243	0.000314	CcSEcCtD
Pramipexole—Convulsion—Doxorubicin—sarcoma	0.000243	0.000313	CcSEcCtD
Pramipexole—Nervous system disorder—Epirubicin—sarcoma	0.000243	0.000313	CcSEcCtD
Pramipexole—Thrombocytopenia—Epirubicin—sarcoma	0.000242	0.000312	CcSEcCtD
Pramipexole—Hypertension—Doxorubicin—sarcoma	0.000242	0.000312	CcSEcCtD
Pramipexole—Tachycardia—Epirubicin—sarcoma	0.000241	0.000311	CcSEcCtD
Pramipexole—Skin disorder—Epirubicin—sarcoma	0.00024	0.00031	CcSEcCtD
Pramipexole—Hyperhidrosis—Epirubicin—sarcoma	0.000239	0.000308	CcSEcCtD
Pramipexole—Chest pain—Doxorubicin—sarcoma	0.000239	0.000308	CcSEcCtD
Pramipexole—Myalgia—Doxorubicin—sarcoma	0.000239	0.000308	CcSEcCtD
Pramipexole—Arthralgia—Doxorubicin—sarcoma	0.000239	0.000308	CcSEcCtD
Pramipexole—Anxiety—Doxorubicin—sarcoma	0.000238	0.000307	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000237	0.000306	CcSEcCtD
Pramipexole—Discomfort—Doxorubicin—sarcoma	0.000236	0.000304	CcSEcCtD
Pramipexole—Anorexia—Epirubicin—sarcoma	0.000236	0.000304	CcSEcCtD
Pramipexole—Dry mouth—Doxorubicin—sarcoma	0.000233	0.000301	CcSEcCtD
Pramipexole—Hypotension—Epirubicin—sarcoma	0.000231	0.000298	CcSEcCtD
Pramipexole—Confusional state—Doxorubicin—sarcoma	0.000231	0.000297	CcSEcCtD
Pramipexole—Oedema—Doxorubicin—sarcoma	0.000229	0.000295	CcSEcCtD
Pramipexole—Infection—Doxorubicin—sarcoma	0.000227	0.000293	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000225	0.00029	CcSEcCtD
Pramipexole—Shock—Doxorubicin—sarcoma	0.000225	0.00029	CcSEcCtD
Pramipexole—Nervous system disorder—Doxorubicin—sarcoma	0.000224	0.000289	CcSEcCtD
Pramipexole—Thrombocytopenia—Doxorubicin—sarcoma	0.000224	0.000289	CcSEcCtD
Pramipexole—Insomnia—Epirubicin—sarcoma	0.000224	0.000288	CcSEcCtD
Pramipexole—Tachycardia—Doxorubicin—sarcoma	0.000223	0.000288	CcSEcCtD
Pramipexole—Skin disorder—Doxorubicin—sarcoma	0.000222	0.000286	CcSEcCtD
Pramipexole—Paraesthesia—Epirubicin—sarcoma	0.000222	0.000286	CcSEcCtD
Pramipexole—Hyperhidrosis—Doxorubicin—sarcoma	0.000221	0.000285	CcSEcCtD
Pramipexole—Dyspnoea—Epirubicin—sarcoma	0.00022	0.000284	CcSEcCtD
Pramipexole—Somnolence—Epirubicin—sarcoma	0.00022	0.000283	CcSEcCtD
Pramipexole—Anorexia—Doxorubicin—sarcoma	0.000218	0.000281	CcSEcCtD
Pramipexole—Dyspepsia—Epirubicin—sarcoma	0.000218	0.000281	CcSEcCtD
Pramipexole—Decreased appetite—Epirubicin—sarcoma	0.000215	0.000277	CcSEcCtD
Pramipexole—Hypotension—Doxorubicin—sarcoma	0.000214	0.000276	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Epirubicin—sarcoma	0.000213	0.000275	CcSEcCtD
Pramipexole—Fatigue—Epirubicin—sarcoma	0.000213	0.000275	CcSEcCtD
Pramipexole—Constipation—Epirubicin—sarcoma	0.000211	0.000273	CcSEcCtD
Pramipexole—Pain—Epirubicin—sarcoma	0.000211	0.000273	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000208	0.000269	CcSEcCtD
Pramipexole—Insomnia—Doxorubicin—sarcoma	0.000207	0.000267	CcSEcCtD
Pramipexole—Paraesthesia—Doxorubicin—sarcoma	0.000205	0.000265	CcSEcCtD
Pramipexole—Dyspnoea—Doxorubicin—sarcoma	0.000204	0.000263	CcSEcCtD
Pramipexole—Feeling abnormal—Epirubicin—sarcoma	0.000204	0.000263	CcSEcCtD
Pramipexole—Somnolence—Doxorubicin—sarcoma	0.000203	0.000262	CcSEcCtD
Pramipexole—Gastrointestinal pain—Epirubicin—sarcoma	0.000202	0.000261	CcSEcCtD
Pramipexole—Dyspepsia—Doxorubicin—sarcoma	0.000201	0.00026	CcSEcCtD
Pramipexole—Decreased appetite—Doxorubicin—sarcoma	0.000199	0.000256	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000198	0.000255	CcSEcCtD
Pramipexole—Fatigue—Doxorubicin—sarcoma	0.000197	0.000254	CcSEcCtD
Pramipexole—Urticaria—Epirubicin—sarcoma	0.000196	0.000253	CcSEcCtD
Pramipexole—Constipation—Doxorubicin—sarcoma	0.000196	0.000252	CcSEcCtD
Pramipexole—Pain—Doxorubicin—sarcoma	0.000196	0.000252	CcSEcCtD
Pramipexole—Abdominal pain—Epirubicin—sarcoma	0.000195	0.000252	CcSEcCtD
Pramipexole—Body temperature increased—Epirubicin—sarcoma	0.000195	0.000252	CcSEcCtD
Pramipexole—Feeling abnormal—Doxorubicin—sarcoma	0.000189	0.000243	CcSEcCtD
Pramipexole—Gastrointestinal pain—Doxorubicin—sarcoma	0.000187	0.000241	CcSEcCtD
Pramipexole—Hypersensitivity—Epirubicin—sarcoma	0.000182	0.000235	CcSEcCtD
Pramipexole—Urticaria—Doxorubicin—sarcoma	0.000182	0.000234	CcSEcCtD
Pramipexole—Body temperature increased—Doxorubicin—sarcoma	0.000181	0.000233	CcSEcCtD
Pramipexole—Abdominal pain—Doxorubicin—sarcoma	0.000181	0.000233	CcSEcCtD
Pramipexole—Asthenia—Epirubicin—sarcoma	0.000177	0.000229	CcSEcCtD
Pramipexole—Pruritus—Epirubicin—sarcoma	0.000175	0.000226	CcSEcCtD
Pramipexole—Diarrhoea—Epirubicin—sarcoma	0.000169	0.000218	CcSEcCtD
Pramipexole—Hypersensitivity—Doxorubicin—sarcoma	0.000169	0.000217	CcSEcCtD
Pramipexole—Asthenia—Doxorubicin—sarcoma	0.000164	0.000212	CcSEcCtD
Pramipexole—Dizziness—Epirubicin—sarcoma	0.000164	0.000211	CcSEcCtD
Pramipexole—Pruritus—Doxorubicin—sarcoma	0.000162	0.000209	CcSEcCtD
Pramipexole—Vomiting—Epirubicin—sarcoma	0.000157	0.000203	CcSEcCtD
Pramipexole—Diarrhoea—Doxorubicin—sarcoma	0.000157	0.000202	CcSEcCtD
Pramipexole—Rash—Epirubicin—sarcoma	0.000156	0.000201	CcSEcCtD
Pramipexole—Dermatitis—Epirubicin—sarcoma	0.000156	0.000201	CcSEcCtD
Pramipexole—Headache—Epirubicin—sarcoma	0.000155	0.0002	CcSEcCtD
Pramipexole—Dizziness—Doxorubicin—sarcoma	0.000151	0.000195	CcSEcCtD
Pramipexole—Nausea—Epirubicin—sarcoma	0.000147	0.000189	CcSEcCtD
Pramipexole—Vomiting—Doxorubicin—sarcoma	0.000145	0.000188	CcSEcCtD
Pramipexole—Rash—Doxorubicin—sarcoma	0.000144	0.000186	CcSEcCtD
Pramipexole—Dermatitis—Doxorubicin—sarcoma	0.000144	0.000186	CcSEcCtD
Pramipexole—Headache—Doxorubicin—sarcoma	0.000143	0.000185	CcSEcCtD
Pramipexole—Nausea—Doxorubicin—sarcoma	0.000136	0.000175	CcSEcCtD
